Incyte

NEWS

Lilly, Incyte Report Positive Data for JAK Inhibitor in Phase III Alopecia Trial

The topline data from the BRAVE-AA2 study in 546 adults showed both 2 mg and 4 mg doses of Olumiant regrew hair in adult patients with more than 50% scalp hair loss, compared with placebo.

March 3, 2021

2 min read

Mark Zipkin

Drug Development

Clinical Catch-Up: December 14-18

Many companies appear to be getting their clinical trial news updated ahead of the holidays. Here’s a look.

December 18, 2020

13 min read

Mark Terry

Drug Development

Biopharma Update on the Novel Coronavirus: December 15

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.

December 15, 2020

3 min read

BioSpace Editorial Staff

Drug Development

Biopharma Update on the Novel Coronavirus: November 24

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 24, 2020.

November 23, 2020

5 min read

BioSpace Editorial Staff

BioForest

Clinical Catch-Up: November 2-6

It was relatively quiet in terms of COVID-19-related clinical trials, but there was still quite a bit of news for trials involving other indications. Here’s a look.

November 6, 2020

9 min read

Mark Terry

BioCapital

Clinical Catch-Up: October 5-9

It was a moderately busy week for clinical trial news. Here’s a look.

October 9, 2020

9 min read

Mark Terry

Drug Development

ESMO: Merck and AstraZeneca’s 5-Year Lynparza Data in Ovarian Cancer and More

Biopharma companies focused on oncology continue to release data that will be presented at the 2020 virtual meeting of the European Society of Medical Oncology.

September 18, 2020

4 min read

Alex Keown

BioForest

Clinical Catch-Up: September 14-18

It was a fairly busy week for clinical trial announcements, with some important and interesting news about COVID-19 treatments and vaccines, as well as numerous stories about non-COVID-19 studies.

September 18, 2020

11 min read

Mark Terry